耐火性皮肤伪淋巴瘤用tapinarof治疗
Shravya Kichena1, Emily Limmer2, Dario Kivelevitch2,3,4
1Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, USA.
Proceedings (Baylor University. Medical Center)
|August 18, 2025
概括
本案例研究探讨了tapinarof奶油用于治疗皮肤伪淋巴瘤 (CPL),一种模仿淋巴瘤的疾病. 塔皮纳罗夫在耐火性CPL患者中显示出有前途的结果,表明其作为新疗法选择的潜力.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
背景情况:
- 皮肤伪淋巴瘤 (CPL) 是一种良性淋巴增殖性疾病,模仿皮肤淋巴瘤.
- 正确的诊断和有效的治疗可能是具有挑战性的,因为它呈现的变化.
相关概念视频
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660